Sweden: Oncopeptides appoints Monica Shaw to CEO position as company moves to commercialize Pepaxti

Oncopeptides, a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, has appointed Dr Monica Shaw as Chief Executive Officer, CEO, of Oncopeptides. She replaces Jakob Lindberg, who has been the CEO since November 15, 2021. Lindberg assumes his previous position as Chief Scientific Officer (CSO). Shaw brings a wealth of…